Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 585-593

  Lichtman, Aron H ^a   Cook, Stacie A ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANALGESIC AGENT; BORDETELLA VIRULENCE FACTOR; BUCLADESINE; CANNABINOID; CYCLOHEXANOL DERIVATIVE; PERTUSSIS TOXIN; TETRAHYDROCANNABINOL;

ANIMAL; ARTICLE; CAUDATE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; PERIAQUEDUCTAL GRAY MATTER; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STEREOISOMERISM;

ANALGESICS; ANIMALS; BUCLADESINE; CANNABINOIDS; CAUDATE NUCLEUS; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; MALE; PERIAQUEDUCTAL GRAY; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; TETRAHYDROCANNABINOL; VIRULENCE FACTORS, BORDETELLA;

EID: 0030087731     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. ABOOD, M. E. AND MARTIN, B. R.: Neurobiology of marijuana abuse Trends Pharmacol. Sci. 13: 201-207, 1992
2. AMIR, S.: Catalepsy induced by body pinch Relation to stress-induced analgesia. Ann. N.Y. Acad. Sci. 467: 226-237, 1986.
3. BASBAUM, A. I. AND FIELDS, H. L.: Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7: 309-338, 1984.
4. BERGE, O.-G., GARCIA-CABRERA, I. AND HOLE, K.: Response latencies in the tail-flick test depend on tail skin temperature. Neurosci. Lett. 86: 284-288, 1988.
5. BODNAR, R. J., PAUL, D., ROSENBLUM, M., LIU, L AND PASTERNAK, G. W.: Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Res. 529: 324-328, 1990.
6. BROWN, A. M. AND BIRNBAUMER, L.: Ionic channels and their regulation by G protein subunits. Annu. Rev. Physiol. 52: 197-213, 1990.
7. BURTON, C. K., Ho, I. K. AND HOSKINS, B.: Effect of cyclo(Leu-Gly) on cyclic GMP-phosphodiesterase activity changes associated with development of tolerance to morphine-induced antinociception, catalepsy, respiratory depression and mydriasis. J. Pharmacol. Exp. Ther. 258: 871-876, 1991.
8. CAULFIELD, M. P. AND BROWN, D. A.: Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106: 231-232, 1992.
9. CHILDERS, S. R., FLEMING, L., KONKOY, C., MARCKEL, D., PACHECO, M., SEXTON, T. AND WARD, S.: Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Ann. N.Y. Acad. Sci. 654: 33-51, 1992.
10. 9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 263: 1118-1126, 1992a.
11. COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacological profile of a series of bicyclic cannabinoid analogs-classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260: 201-209, 1992b.
12. COMPTON, D. R., RICE, K. C., COSTA, B. R. D., RAZDAN, R. K., MELVIN, L. S., JOHNSON, M. R. AND MARTIN, B. R.: Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218-226, 1993.
13. DAMAJ, M. I., WELCH, S. P. AND MARTIN, B. R.: Nicotine-induced antinociception in mice: Role of G-proteins and adenylate cyclase. Pharmacol. Bichem. Behav. 48: 37-42, 1994.
14. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79, 1941.
15. DEUTSCH, D. G. AND CHIN, S. A.: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46: 791-796, 1993.
16. DEVANE, W. A., DYSARZ, I. F. A., JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
17. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash. DC) 258: 1946-1949, 1992.
18. DEWEY, W. L.: Cannabinoid pharmacology. Pharmacol. Rev. 38: 151-78, 1986
19. FERRI, S., CAVICCHINI, E., ROMUALDI, P., SPERONI, E. AND MURARI, G.: Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L. Psychopharmacology (Berlin) 89: 244-247, 1986.
20. FRIDE, E. AND MECHOULAM, R.: Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231: 313-314, 1993.
21. GOUGH, A. L. AND OLLEY, J. E.: Catalepsy induced by intrastriatal injections of Δ(9)-THC and 11-OH-Δ(9)-THC in the rat Neuropharmacology 17: 137-144, 1978.
22. GUIMARAES, A. P. C. AND PRADO, W. A.: Antinociceptive effects of carbachol microinjected into different portions of the mesencephalic periaqueductal gray matter or the rat. Brain Res. 647: 220-230, 1994.
23. HERKENHAM, M., LYNN, A. B., JOHNSON, M. R., MELVIN, L. S., DE COSTA, B. R. AND RICE, K. C.: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci 11: 563-583, 1991.
24. HOEHN, K., REID, A. AND SAWNOK, J.: Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen. Eur. J. Pharmacol. 146: 65-72, 1988.
25. HOWLETT, A. C., JOHNSON, M. R., MELVIN, L. S. AND MILNE, G. M.: Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol. Pharmacol. 33: 297-302, 1988.
26. HOWLETT, A. C., QUALY, J. M. AND KHACHATRIAN, L. L.: Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs Mol. Pharmacol. 29: 307-313, 1986.
27. IRWIN, S. I., HOUDE, R. W., BENNETT, D. B., HENDERSHOT, L. C. AND SEEVERS, M H.: The effects of morphine methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther. 99: 132-143, 1950.
28. JANSEN, E. M., HAYCOCK, D. A., WARD, S. J. AND SEYBOLD, V. S.: Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575: 93-102, 1992.
29. JENSEN, T. S. AND YAKSH, T. L.: Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res. 321: 287-297, 1984.
30. LICHTMAN, A. H., DIMEN, K. R. AND MARTIN, B. R.: Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282-290, 1995.
31. LICHTMAN, A. H. AND MARTIN, B. R., Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258: 517-523, 1991a.
32. 2 noradrenergic mechanism. Brain Res 559: 309-314, 1991b.
33. LICHTMAN, A. H., SMITH, F. L. AND MARTIN, B. R : Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature. Pain 55: 283-295, 1993.
34. LICHTMAN, A. H., SMITH, P. B. AND MARTIN, B. R.: The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity. Pain 51: 19-26, 1992.
35. LITTLE, P. J., COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther. 247: 1046-1051, 1988.
36. LUND, A., TJOLSEN, A AND HOLE, K.: The apparent antinociceptive effects of desipramine and zimelidine in the tail flick test in rats is mainly caused by changes in tail skin temperature. Pain 38: 65-69, 1989.
37. MACKIE, K., DEVANE, W. AND HILLE, B.: Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells Mol. Pharmacol. 44: 498-503, 1993.
38. MACKIE, K. AND HILLE, B.: Cannabinoids inhibit N-type calcium channels in neurobalstoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89: 3825-3829, 1992.
39. MARTIN, B. R.: Cellular effects of cannabinoids. Pharmacol. Rev. 38: 45-74, 1986.
40. MARTIN, B. R., PRESCOTT, W. R. AND ZHU, M.: Quantitation of rodent catalepsy by a computer-imaging technique. Pharmacol. Biochem. Behav 43: 381-386, 1992.
41. MARTIN, B. R., WELCH, S. P. AND ABOOD, M. E.: Progress toward understanding the cannabinoid receptor and its second messenger systems. In Advances in Pharmacology, ed. by J. T. August, M. W. Anders and F. Murad, pp. 341-397, Academic Press, Inc., San Diego, 1994.
42. MARTIN, W. J., Lsi, N. K., PATRICK, S. L., Tsou, K. AND WALKER, J. M.: Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629: 300-304, 1993.
43. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond.) 346: 561-564, 1990.
44. MAYER, D. J. AND LIEBESKIND, J. C.: Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis. Brain Res. 68: 73-93, 1974.
45. MOUNTJOY, K. G., ROBBINS, L. S., MORTRUD, M. T. AND CONE, R. D.: The cloning of a family of genes that encode the melanocortin receptors. Science (Wash. DC) 257: 1248-1251, 1992.
46. NOYES, J. R., BRUNK, S. F., AVERY, D. H. AND CANTER, A.: The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin. Pharmacol. Ther 18: 84-89, 1975.
47. PACHECO, M., CHILDERS, S. R., ARNOLD, R., CASIANO, F. AND WARD, S. J.: Aminoalkylindoles: Actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257: 170-83, 1991.
48. PARENTI, M , TIRONE, F., GIAGNONI, G., PECORA, N. AND PAROLARO, D.: Pertussis toxin inhibits the antinociceptive action of morphine in the rat. Eur. J. Pharmacol. 124: 357-359, 1986.
49. PAROLARO, D., PATRINI, P , GIAGNONI, G., MASSI, P., GROPPETTI, A. AND PARENTI, M., Pertussis toxin inhibits morphine analgesia and prevents opiate dependence. Pharmacol. Biochem. Behav. 35: 137-141, 1990.
50. PAROLARO, D , SALA, M., CREMA, G., GIAGNON, I. G. AND GORI, E.: Cerebral sites of central action of dermorphin on intestinal motility in the rat. Peptides 6: 149-153, 1985.
51. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA, 1986.
52. PERTWEE, R. G.: The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br. J. Pharmacol. 46: 753-63, 1972.
53. PERTWEE, R. G. AND WICKENS, A. P.: Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology 30: 237-244, 1991.
54. PRZEWLOCKI, R., COSTA, T , LANG, J. AND HERZ, A.: Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord. Eur. J. Pharmacol 144: 91-95, 1987.
55. RAZDAN, R. K.: Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38: 75-149, 1986.
56. REN, M. F. AND HAN, J. S.: Rat tail flick acupuncture model. Chin. Med. J. 92: 576-582, 1979.
57. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J. C. AND LE FUR, G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
58. SANCHEZ-BLAZQUEZ, P. AND GARZON, J.: Pertussis toxin reduces the efficacy of opioids to produce supraspinal analgesia in the mouse. Eur. J. Pharmacol. 152: 357-361, 1988.
59. SMITH, D. J., ROBERTSON, B. AND MONROE, P. J.: Antinociception from the administration of beta-endorphin into the periaqueductal gray of rat is enhanced while that of morphine is inhibited by barbiturate anesthesia. Neurosci. Lett. 146: 143-146, 1992.
60. SMITH, P. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270: 219-227, 1994.
61. 9-tetrahydrocannabinol-induced analgesia. Brain Res 578: 8-12, 1992.
62. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag, New York, 1987.
63. THOMAS, B. F., COMPTON, D. R., MARTIN, B. R. AND SEMUS, S. F.: Modeling the cannabinoid receptor: A three-dimensionl quantitative structure-activity analysis. Mol. Pharmacol. 40: 656-665, 1991.
64. 9-THC-DMH. J. Pharmacol. Exp. Ther. 263: 1383-1390, 1992.
65. VOGEL, Z., BERG, J., LEVY, R., SAYA, D., HELDMAN, E. AND MECHOULAM, R.: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61: 352-355, 1993.
66. WELCH, S. P.: Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice. J. Pharmacol. Exp. Ther. 265: 633-640, 1993.
67. WELCH, S. P., THOMAS, C. AND PATRICK, G S.: Modulation of cannabinoid-induced antinociception following intracerebroventricular versus intrathecal administration to mice: Possible mechanisms for interaction with morphine. J. Pharmacol. Exp. Ther. 272: 310-321, 1095.
68. YAKSH, T. L : Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in periaqueductal gray. Brain Res 160: 180-185, 1979.
69. YAKSH, T. L., The antincociceptive effects of intrathecally-administered levonantradol and desacetyllevonantradol in the rat. J. Clin. Pharmacol. 21: 334S-340S, 1981.
70. YAKSH, T. L. AND RUDY, T. A.: Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J. Pharmacol. Exp. Ther. 202: 411-428, 1977.
71. YAKSH, T. L., YEUNG, J. C. AND RUDY, T. A.: Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 114: 83-103, 1976.
72. YEUNG, J. C AND RUDY, T. A : Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J. Pharmacol. Exp Ther. 215: 633-642, 1980.